Firefighter Thermoregulatory Responses in Active Fire With Betaine Supplementation (FFBET)

April 3, 2024 updated by: Michael J. Ormsbee

Thermoregulatory Responses of Betaine Supplementation in Firefighters During Live Burn

The goal of this clinical trial is to compare betaine supplementation to placebo in firefighters undergoing live burn training regarding thermoregulation and inflammation. The main questions it aims to answer are:

  • Does betaine supplementation mitigate rises in core temperature during firefighter live burn training?
  • Does betaine supplementation decrease inflammation from firefighter training?
  • Does betaine supplementation increase total body water stores?

Participants will supplement with betaine for 1 month and complete:

  • Total Body Water measures
  • Body Composition measures
  • Live Burn training with Core Temperature Measurements
  • Provide Salivary samples

Study Overview

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Liliana Renteria
  • Phone Number: 8506451016
  • Email: lir20@fsu.edu

Study Contact Backup

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32301
        • Institute of Sports Science and Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Structural Firefighter

Exclusion Criteria:

  • • Participants have a cardiometabolic disease for which they take prescribed medications

    • Participants consume supplements known to impact hydration status or performance that they are not willing to stop taking for the study
    • Participants are pregnant
    • Female participants that have irregular menstrual cycles
    • Participants are injured and would not be able to fulfill the live burn scenario
    • Participants have sickle cell disease
    • Participants have experienced heat stroke within the last 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
10 participants will be given rice-flour as a placebo
3 grams per day for ~4 weeks
Other Names:
  • Rice Flour
Active Comparator: Betaine
10 participants will be given betaine
3 grams per day for ~4 weeks
Other Names:
  • Trimethylglycine
  • Betaine Anhydrous

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thermoregulation
Time Frame: 10 minutes before the live burn, during the ~15 minute live burn, 10, 20, and 30 minutes after the live burn.
Core temperature (Degrees C), skin temperature (Degrees C)
10 minutes before the live burn, during the ~15 minute live burn, 10, 20, and 30 minutes after the live burn.
Stress (enzyme linked immunoassays)
Time Frame: before, immediately after, 10 minutes, and 20 minutes after live burn
Salivary expression of Testosterone, Cortisol, interleukin-8, and interleukin 6 will be measured.
before, immediately after, 10 minutes, and 20 minutes after live burn
Stress (respiration efficiency)
Time Frame: immediately before and immediately after the completion of the live burn
Air tank pounds per square inch (PSI) will be recorded
immediately before and immediately after the completion of the live burn
Sweat Rate
Time Frame: immediately before and immediately after the completion of the live burn
Changes in body weight in kg will be used to find loss of sweat in L
immediately before and immediately after the completion of the live burn
Sweat Content
Time Frame: immediately before and immediately after the completion of the live burn
Tegaderm patches will be worn during the live burn to analyze sodium concentration in sweat.
immediately before and immediately after the completion of the live burn
Subjective measures
Time Frame: immediately before and immediately after the completion of the live burn
Visual analog scales will be given to participants for subjective thermal sensation, rate of perceived exertion, and thirst
immediately before and immediately after the completion of the live burn

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chronic Stress (enzyme linked immunoassays)
Time Frame: Before supplementation and after 4 weeks of supplementation
Saliva will be analyzed for testosterone, cortisol, uric acid, and c-reactive protein
Before supplementation and after 4 weeks of supplementation
Chronic Stress (vitals) professional firefighters.
Time Frame: Before supplementation and after 4 weeks of supplementation
Resting blood pressure in mmHg and heart rate in beats per minute will be measured.
Before supplementation and after 4 weeks of supplementation
Fluid Compartment Volumes (Bioelectrical Impedance Spectrocopy) professional firefighters.
Time Frame: Before supplementation and after 4 weeks of supplementation
Intracellular fluid volume (L), extracellular fluid volume (L), plasma volume (L), total body water (L)
Before supplementation and after 4 weeks of supplementation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2023

Primary Completion (Actual)

March 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

August 25, 2023

First Submitted That Met QC Criteria

September 11, 2023

First Posted (Actual)

September 18, 2023

Study Record Updates

Last Update Posted (Actual)

April 4, 2024

Last Update Submitted That Met QC Criteria

April 3, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

Clinical Trials on Placebo

3
Subscribe